Umbilical cord-derived mesenchymal stem cells to treat ankylosing spondylitis
The purpose of this study was to evaluate the safety and efficacy of mesenchymal stem cells (MSCs) derived from human umbilical cord/placenta in treating ankylosing spondylitis.
Read More
Product Information for
Umbilical cord-derived mesenchymal stem cells to treat ankylosing spondylitis